These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6085395)

  • 61. Choice-option evaluation is preserved in early Huntington and Parkinson's disease.
    Minati L; Piacentini S; Ferrè F; Nanetti L; Romito L; Mariotti C; Grisoli M; Medford N; Critchley HD; Albanese A
    Neuroreport; 2011 Oct; 22(15):753-7. PubMed ID: 21876465
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Caring for stoma patients with arthritis and mental incapacities.
    Black P
    Br J Community Nurs; 2015 Oct; 20(10):487-92. PubMed ID: 26418401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Huntington's chorea and Parkinson's disease. Physiopathological antagonism in relation to the blink reflex].
    Esteban A; Gimenez-Roldan S
    Arch Neurobiol (Madr); 1974; 37(4):337-54. PubMed ID: 4279639
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Cote L; Williams JB
    Neurology; 1987 Jul; 37(7):1130-4. PubMed ID: 2439947
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 66. The premorbid personality of patients with Parkinson's disease: a comparative study with healthy controls and patients with essential tremor.
    Poewe W; Karamat E; Kemmler GW; Gerstenbrand F
    Adv Neurol; 1990; 53():339-42. PubMed ID: 2239474
    [No Abstract]   [Full Text] [Related]  

  • 67. [Neurotransmitters and degenerative diseases in the central nervous system].
    Nakamura S
    Nihon Ronen Igakkai Zasshi; 1986 Jan; 23(1):11-6. PubMed ID: 2423726
    [No Abstract]   [Full Text] [Related]  

  • 68. Parkinson's disease and dementia: clinical and neurochemical correlations.
    Strittmatter MM; Cramer H
    Neuroreport; 1992 May; 3(5):413-6. PubMed ID: 1378766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Problems associated with fluid biomarkers for Parkinson's disease.
    Nyhlén J; Constantinescu R; Zetterberg H
    Biomark Med; 2010 Oct; 4(5):671-81. PubMed ID: 20945980
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human aggression and suicide.
    Brown GL; Goodwin FK
    Suicide Life Threat Behav; 1986; 16(2):223-43. PubMed ID: 2428140
    [No Abstract]   [Full Text] [Related]  

  • 71. [Reactive syndromes in Huntington's disease].
    Leszek J; Kiejna A; Juskowiak A; Sanecka B; Baran G
    Psychiatr Pol; 1988; 22(5):387-90. PubMed ID: 2977444
    [No Abstract]   [Full Text] [Related]  

  • 72. Fusaric acid in Parkinson's disease.
    Chase TN
    Neurology; 1974 Jul; 24(7):637-9. PubMed ID: 4858086
    [No Abstract]   [Full Text] [Related]  

  • 73. Levodopa and Huntington's chorea.
    Loeb C; Roccatagliata G; La Medica G; Abbruzzese G; Albano C
    J Neurol Neurosurg Psychiatry; 1976 Oct; 39(10):958-61. PubMed ID: 137301
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Confrontation naming impairment in dementia.
    Bayles KA; Tomoeda CK
    Brain Lang; 1983 May; 19(1):98-114. PubMed ID: 6222782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia.
    Gottfries CG; Gottfries I; Roos BE
    Acta Psychiatr Scand; 1970; 46(2):99-105. PubMed ID: 5478542
    [No Abstract]   [Full Text] [Related]  

  • 76. Retrograde amnesia in Parkinson's disease.
    Freedman M; Rivoira P; Butters N; Sax DS; Feldman RG
    Can J Neurol Sci; 1984 May; 11(2):297-301. PubMed ID: 6234056
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alcoholism and suicide.
    Roy A; Linnoila M
    Suicide Life Threat Behav; 1986; 16(2):244-73. PubMed ID: 2428141
    [No Abstract]   [Full Text] [Related]  

  • 78. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
    Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Neuropsychiatry Of Movement Disorders].
    Orjuela-Rojas JM; Barrios Vincos GA; Martínez Gallego MA
    Rev Colomb Psiquiatr; 2017 Oct; 46 Suppl 1():59-68. PubMed ID: 29037340
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The threshold of pain and neurotransmitter's change on pain in Parkinson's disease.
    Urakami K; Takahashi K; Matsushima E; Sano K; Nishikawa S; Takao T
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):589-93. PubMed ID: 1705999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.